Embryonal Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Avelumab in Refractory Testicular Germ Cell Cancer.
Conditions:   Testicular Neoplasms;   Neoplasms, Germ Cell and Embryonal;   Neoplasms;   Testicular Diseases;   Gonadal Disorders;   Antineoplastic Agents;   Molecular Mechanisms of Pharmacological Action Intervention:   Drug: Avelumab Sponsors:   National Cancer Institute, Slovakia;   Merck Sharp & Dohme Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2018 Category: Research Source Type: clinical trials

Avelumab in Refractory Testicular Germ Cell Cancer.
Conditions:   Testicular Neoplasms;   Neoplasms, Germ Cell and Embryonal;   Neoplasms;   Testicular Diseases;   Gonadal Disorders;   Antineoplastic Agents;   Molecular Mechanisms of Pharmacological Action Intervention:   Drug: Avelumab Sponsors:   National Cancer Institute, Slovakia;   Merck KGaA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2018 Category: Research Source Type: clinical trials